Quantify

BioNTech SE vs Johnson & Johnson — Stock Comparison

BioNTech SE (BNTX) and Johnson & Johnson (JNJ) are both listed on US exchanges. This page compares their Q·Score ratings, key fundamentals (P/E, margins, growth), and Wall Street analyst consensus side by side. Data sourced from Yahoo Finance and updated on each page load.

vs
Q·Score Winner
Johnson & Johnson
JNJ7.1/10vs 4.7/10

Johnson & Johnson clearly outscores BioNTech SE on Q·Score (7.1 vs 4.7 out of 10), led by Quality (9.3 vs 1.5) and Growth (5.1 vs 2.1). BioNTech SE scores higher on Health, reflecting stronger balance sheet strength. Analyst consensus targets imply greater upside for BNTX (+36.1%) than for JNJ (+7.3%).

Price Performance

Normalised to 100 at period start — shows relative performance.

Loading…
● BNTX● JNJ

Q·Score Breakdown

4.7
Bearish
Overall
7.1
Bullish
1.5
Quality
9.3
7.7
Health
6.5
2.1
Growth
5.1
6.4
Valuation
7
7.2
Sentiment
6.9
BNTX

Clean balance sheet with low leverage (0.0× debt-to-equity).

⚠ currently unprofitable (-45% margin).

JNJ

High-quality business with 26% return on equity and 22% profit margins.

⚠ earnings contracting 53% year-over-year.

Analyst Consensus

Bullish
+36.1%
Target $123.55
19 analysts
Bullish
+7.3%
Target $252.87
23 analysts

Fundamentals

BNTX
JNJ
—
Trailing P/E
27.3×
-17.7×
Forward P/E
18.5×
-44.64%
Profit Margin
21.83%
78.65%
Gross Margin
68.04%
-6.66%
ROE
26.42%
-35.40%
Revenue Growth
9.90%
—
Earnings Growth
-52.90%
1.32
Beta
0.26
—
Dividend Yield
2.27%
$23.0B
Market Cap
$567.3B
52-Week Range
BNTX
$8025% of range$124
JNJ
$14984% of range$252

Frequently Asked Questions

BNTX vs JNJ: which stock scores better overall?

Based on Q·Score, Johnson & Johnson (JNJ) scores 7.1/10 versus BioNTech SE (BNTX) at 4.7/10. The Q·Score measures five dimensions: Quality, Health, Growth, Valuation, and Sentiment. For informational purposes only — not financial advice.

Which has better revenue growth: BNTX or JNJ?

Johnson & Johnson (JNJ) scores higher on Growth (5.1/10 vs 2.1/10). BioNTech SE reports revenue growth (-35.4% YoY) while Johnson & Johnson reports (9.9% YoY). Growth scores reflect revenue and earnings momentum relative to sector peers.

Is BNTX or JNJ more attractively valued?

Johnson & Johnson (JNJ) scores higher on Valuation (7/10 vs 6.4/10). Valuation is assessed using P/E ratio, analyst price targets, and 52-week range positioning relative to sector peers.

What do analysts say about BNTX vs JNJ?

There are 19 analysts covering BNTX with a consensus price target of $123.55, and 23 analysts covering JNJ with a consensus target of $252.87. Analyst consensus ratings are aggregated from Wall Street research and do not constitute investment advice.

Which is more profitable: BNTX or JNJ?

Johnson & Johnson (JNJ) scores higher on Quality (9.3/10 vs 1.5/10). Net profit margin: BNTX at -44.6%, JNJ at 21.8%. Quality scores reflect profit margins, return on equity, and free cash flow generation.

Which has stronger financial health: BNTX or JNJ?

BioNTech SE (BNTX) scores higher on Financial Health (7.7/10 vs 6.5/10). Market beta: BNTX at 1.32, JNJ at 0.26. Health scores consider beta, debt-to-equity, and current ratio. All investments carry risk — this is not investment advice.

What are the market caps of BNTX and JNJ?

BioNTech SE (BNTX) has a market capitalisation of $23.0B, while Johnson & Johnson (JNJ) has a market cap of $567.3B. Market cap data is sourced from Yahoo Finance and reflects the most recent available figures.

Do BNTX or JNJ pay dividends?

BNTX does not currently pay a dividend, while JNJ pays a dividend yield of 2.27%. Dividend yields fluctuate with share price and company payout decisions.

Related Comparisons

JNJ vs PFEABBV vs JNJBNTX vs MRNAJNJ vs MRKAAPL vs JNJ

Q·Score is an educational tool and is not financial advice. Data provided by Yahoo Finance. Updated on each page load. How it's calculated →

Data provided by Yahoo Finance ·  Updated on each page load ·  For informational purposes only · Not financial advice · Quantify.biz © 2026